课题基金 / 基金详情

ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABETES

ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABETES
口服胰岛素可预防有 1 型糖尿病风险的亲属的糖尿病
批准号:
7951735
负责人:
Antoinette M. Moran
金额:
$0.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-01 至 2009-11-30

项目摘要

项目成果

Antoinette M. Moran的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The primary objective of this study is to determine whether intervention with repeated oral administration of recombinant human insulin will prevent or delay the development of clinical Type 1 Diabetes Mellitus (T1DM) in subjects at risk for T1DM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diabetes in African Youth: Improving Glucose Time-In-Range
  • 批准号:
    10565952
  • 项目类别:
  • 资助金额:
    $56.91万
  • 财政年份:
    2022
  • 负责人:
    Antoinette M. Moran
  • 依托单位:
Diabetes in African Youth: Improving Glucose Time-In-Range
  • 批准号:
    10362765
  • 项目类别:
  • 资助金额:
    $59.67万
  • 财政年份:
    2022
  • 负责人:
    Antoinette M. Moran
  • 依托单位:
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients
  • 批准号:
    9294124
  • 项目类别:
  • 资助金额:
    $69.2万
  • 财政年份:
    2015
  • 负责人:
    Antoinette M. Moran
  • 依托单位:
The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic CF Patients
  • 批准号:
    9115576
  • 项目类别:
  • 资助金额:
    $69.2万
  • 财政年份:
    2015
  • 负责人:
    Antoinette M. Moran
  • 依托单位:
海外基金